The quantity at stake is the entropy ratio f(λ), defined as the entropy of the thermal plasma divided by its Stefan-Boltzmann value. At weak coupling, where λ is the ‘t Hooft coupling g²N_c, perturbation theory fixes the expansion order by order: the ratio starts at unity, receives corrections at order λ and λ^(3/2), then a logarithmic term at order λ² log λ, and a constant piece at order λ². At strong coupling, the AdS/CFT duality delivers a different expansion, beginning at 3/4 with a correction proportional to λ^(-3/2) and no terms at λ^(-1/2) or λ^(-1). The trouble is that the crossover region, roughly λ between 1 and 10, sits far outside the domain of validity of both series.

The authors’ earlier work tackled this with constrained Padé ensembles, specifically a log-subtracted two-point Padé, or LSTP, construction. The idea is to subtract the known λ² log λ term, approximate the remainder with a rational function of order [4/4] in a conformal variable z, and then add the logarithm back. The rational function has nine unknown coefficients, fixed by matching the weak expansion at five points and the strong expansion at four points. A parameter scan over the mapping parameter α and the cutoff scale Λ_0, combined with strict admissibility filters requiring the entropy ratio to stay between 0.75 and 1, to decrease monotonically, and to avoid spurious denominator poles, left nine nominal survivors tracing three distinct curves, with crossover values spread across the wide interval from 2.95 to 6.73.

The game changer is the recent exact calculation of the coefficient A_(5/2) at order λ^(5/2), obtained by Carrington, Kunstatter, and Tantary through resummation and effective field theory methods. Its exact analytic value evaluates to approximately 0.7537170300. That number carries real diagnostic weight, because the older Hermite-Padé interpolation route had effectively predicted a value of -43.8 ± 0.1 at this order, wrong in both sign and magnitude. The discrepancy was traced to a spurious λ^(5/2) log λ artifact that the rational structure of the Hermite-Padé ansatz generates at its first unmatched order, a warning that such rational forms cannot be trusted at orders they were never built to match.

When Tantary and Du reran the identical LSTP scan with the exact A_(5/2) included, and shifted the weak-side matching points from very small couplings to intermediate values between 10^(-4) and 1, where the new term is numerically significant, the results were striking. Only three of the twelve parameter combinations survived the filters, all sharing Λ_0 = 4, and because of a numerical degeneracy in the mapping parameter α, those three survivors are numerically identical. The admissible band, which previously had a maximum pointwise width of 0.047 on the range 1 ≤ λ ≤ 10, dropped to below 10^(-15), effectively zero. A broad uncertainty band became a single curve.

The unique survivor places the crossover, defined by the inflection point of f as a function of log λ, at λc ≈ 4.7863, where the entropy ratio equals about 0.8371. Notably, this value sits comfortably inside the old admissible interval, so the upgraded matching narrowed the range rather than displacing the answer outside it. The authors are careful about attribution: because the updated scan changes both the weak-coupling truncation and the matching points simultaneously, the shift relative to other methods cannot be blamed on A(5/2) alone. It is a property of the combined prescription.

Here is where the story takes a twist worthy of a detective novel. The Hermite-Padé route, retained unchanged as a reference, still does not agree with the unique LSTP survivor. Its crossover sits at 3.52, and a related single-curve Padé by Müller gives 3.14, both noticeably below the LSTP value. To make the comparison fair, the authors constructed the minimal extension of the Hermite-Padé ansatz that can also carry the exact A_(5/2): a two-point [6/6] Padé in the variable √λ, with logarithms embedded in the y² and y⁵ coefficients, uniquely determined by fifteen matching conditions. This curve is legitimate, but it develops a near-canceling pole-zero pair on the positive real axis at λ ≈ 0.17956, with a normalized separation of about 10^(-6). The authors identify it as a Froissart doublet, a well-known artifact of rational approximation in which numerator and denominator nearly share a factor, and they verify in 80-digit arithmetic that it is not a rounding error. Evaluated away from the pair, the [6/6] curve gives a crossover near 2.98, even further from the LSTP result.

The disagreement is quantified by a residual estimator, Ŝ₃, which measures how much the interpolant deviates at intermediate coupling from the two known strong-coupling terms. If the true strong expansion contains an unknown coefficient S₃ at order λ^(-3), this estimator would converge to it at large λ. Evaluated at λ = 20, between matching points, the updated LSTP curve gives +2.14, while the old Hermite-Padé curve gives -21.86 and the new [6/6] curve gives -29.77. The routes disagree not just in magnitude but in sign. Since no independent finite-coupling benchmark exists, the authors treat this as a construction-dependent comparison rather than a statement about the true asymptotic coefficient, whose sign will only be settled by an independent strong-coupling calculation, likely requiring higher-order corrections to the type-IIB string effective action.

What makes this work conceptually important is the reframing it forces. The earlier ensemble approach treated interpolation as a prediction problem: build a family of admissible curves and see how much they spread. The new results turn it into a selection problem: given the exact next weak-coupling coefficient, which constructions survive, and how much of the remaining spread reflects genuine route dependence rather than scan uncertainty? The answer is sobering. Even with every known weak-coupling coefficient imposed exactly on both routes, the LSTP and Hermite-Padé curves remain distinct, meaning the presently available perturbative information is insufficient to eliminate all interpolation ambiguity. The missing ingredient is the next strong-coupling coefficient at order λ^(-3), a major calculation in its own right.

For the broader community, the lesson is methodological as much as physical. Rational interpolation schemes are powerful but treacherous: they can generate spurious logarithms, Froissart doublets, and route-dependent answers that look authoritative yet disagree in sign. By systematically upgrading the weak-side input and watching a nine-candidate ensemble collapse to a single curve, while documenting exactly which ambiguities persist, Tantary and Du have provided both a sharper estimate of thermal N=4 SYM thermodynamics and a cautionary map of where interpolation-based intuition can still go wrong. The unique LSTP curve now stands as the tightest weak-side-constrained estimate available, awaiting the day that string theory delivers the next strong-coupling coefficient to judge it by.

Subject of Research: Constrained Padé interpolation of thermal N=4 supersymmetric Yang-Mills thermodynamics using the exact O(λ^(5/2)) weak-coupling coefficient

Article Title: Constrained Padé ensembles for thermal (\mathcal {N}{=}~4) SYM with the exact (\mathcal {O}(\lambda ^{5/2})) coefficient

Article References: Tantary, U., & Du, Q. (2026). Constrained Padé ensembles for thermal $$\mathcal {N}{=}~4$$ SYM with the exact $$\mathcal {O}(\lambda ^{5/2})$$ coefficient. The European Physical Journal C, 86(9), Article 1036. https://doi.org/10.1140/epjc/s10052-026-16307-6

Image Credits: AI Generated

DOI: 10.1140/epjc/s10052-026-16307-6

Keywords: N=4 SYM, Padé interpolation, AdS/CFT, thermal thermodynamics, weak coupling, strong coupling, crossover, Froissart doublet, Hermite-Padé, entropy ratio, conformal map, theoretical physics

The study, published in Advanced Biotechnology, rested on an ambitious sequencing effort. The researchers generated more than fifty-fold short-read whole-genome sequencing coverage for each of 106 individuals from a two-generation family: two parents and 104 F1 offspring. Rather than aligning these reads to an existing reference genome, which would have failed because of the low sequence similarity between the laboratory animals and the published assembly, the team used Platanus-allee, a haplotype-aware assembler designed for highly heterozygous regions, to assemble each parent’s genome de novo. In these assemblies, heterozygous regions appear as paired ‘bubble’ contigs, with a longer primary sequence and a shorter secondary sequence representing the two alleles. Homozygous regions, by contrast, collapse into single non-bubble contigs. Merging the two parental assemblies produced a custom reference to which offspring reads could be mapped accurately, because offspring inherit their DNA directly from these parents.

The logic of the recombination detection is elegant. Each bubble contig pair acts as a biallelic marker: an offspring can inherit either the primary or the secondary contig from a given parent, but not both. Using the R package hapi, the researchers phased these markers and reconstructed chromosome-level haplotypes for each parent. Any switch in the parental haplotype along an offspring’s chromosome signals a crossover (CO) event that occurred during that parent’s meiosis. Because bubble contigs can themselves contain internal crossovers, the team also searched for breakpoints within contigs, where reads from an offspring align to complementary segments of both the primary and secondary contigs, generating four distinct haplotypes in the offspring population. Benchmarking with simulated meioses across a gradient of heterozygosity levels and family sizes showed that when parental heterozygosity exceeded 0.01 and more than 20 offspring were sequenced, the strategy recovered roughly 95 percent of simulated crossovers, with most misses confined to chromosome termini lacking marker coverage.

The results paint a vivid picture of amphioxus meiosis. Across all offspring, the researchers identified 2,329 paternal and 2,288 maternal crossovers, averaging 22.4 and 22.0 events per meiosis respectively. After adjusting for approximately 9 megabases of uncallable chromosome-end regions, this translates into recombination rates of 4.66 centimorgans per megabase in the father and 4.57 cM/Mb in the mother, substantially higher than the roughly 0.5 cM/Mb typical of mammals and the approximately 2 cM/Mb seen in birds. The authors note, however, that this elevated rate per unit of DNA partly reflects the compact size of the amphioxus genome: averaged per haploid chromosome, the count of about 1.2 crossovers per meiosis is close to that of vertebrates. Strikingly, unlike in humans and several other vertebrates where one sex shows markedly higher recombination, no significant sex bias emerged in either the quantity or the chromosomal distribution of crossovers, with paternal and maternal distributions correlating strongly across the genome.

One of the most intriguing findings concerns recombination coldspots. The paternal genome contained roughly 209 megabases of regions spanning at least five megabases with no crossovers in any offspring, while the maternal genome harbored about 142 megabases. These coldspots could not be explained by marker sparsity, since many showed dense marker coverage while crossovers were detected in marker-poor regions elsewhere. Instead, the evidence points to large-scale heterozygous inversions. Amphioxus genomes are known to carry structural variation rates approximately thirty times higher than those observed between humans and chimpanzees, and the team identified four large heterozygous inversions in the parental genomes, all situated within coldspots. In one maternal example on chromosome 3, one haplotype carried an inversion spanning roughly 1.4 to 13.5 megabases, likely preventing crossovers by disrupting pairing and recombination repair in that region. Because inversion polymorphisms appear common in wild amphioxus populations, individual genomes may differ substantially in where recombination is suppressed, which may explain why the pedigree-based crossover map correlated only weakly with historical recombination rates inferred from population genomic variation.

The analysis also probed crossover interference, the phenomenon by which one crossover reduces the likelihood of another nearby. About a quarter of chromosomes in the offspring carried two or more crossovers in both parental genomes. After excluding coldspots and comparing observed inter-crossover distances with a shuffled null distribution, paternal crossovers showed no evidence of interference, while maternal crossovers exhibited significant negative interference, meaning one crossover actually increased the chance of another nearby (Wilcoxon signed-rank test, p = 7.07 x 10^-8). Negative interference remains rare among studied species and its molecular basis is largely unknown, making this maternal effect in amphioxus a curious exception that may shed light on how interference mechanisms evolve across chordates. The researchers also detected crossovers near the sex-determining region on the fused chromosome 16-20 in the paternal genome but not the maternal one, consistent with recombination suppression in the heterogametic ZW sex of this species.

Examining genomic features, the team found that crossover density correlated positively with transposable element density in both parents, with Pearson correlations of 0.43 in the father and 0.40 in the mother, and all major TE classes, including SINEs, LINEs, LTRs, MITEs and DNA transposons, individually showed significant associations. This positive relationship contrasts with the negative correlation often reported in other organisms, underscoring the complex and lineage-dependent interplay between transposable elements and recombination. Gene density also correlated with crossover rates, though more weakly, plausibly reflecting the more open chromatin configuration of gene-rich regions that facilitates binding of recombination proteins. GC content showed no significant correlation with paternal crossovers and only a weak negative correlation with maternal ones, suggesting that amphioxus recombination is not strongly shaped by base composition, unlike in many mammals where PRDM9-directed hotspots often coincide with GC-rich sequence.

Beyond crossovers, the high heterozygosity of amphioxus enabled an unusually sensitive search for non-crossover (NCO) gene conversion events, in which a short segment of one homolog is copied onto the other without a reciprocal exchange. Within analyzable bubble regions, the researchers identified 9,992 paternal and 5,850 maternal NCO events, averaging 96.1 and 56.3 per offspring. Most tracts were short, with 90.9 percent under 200 base pairs and an average length of 99 base pairs, and 83.6 percent covered only a single converted marker. Extrapolated genome-wide, the NCO-to-CO ratios of 28.8 in males and 20.5 in females far exceed those reported for humans and zebra finch, although the authors caution that the amphioxus figures may be inflated by the exceptional marker density and are likely underestimates overall since NCOs in marker-free regions cannot be detected. The conversion spectrum revealed GC-biased gene conversion, favoring C/G over A/T alleles, in most event classes, particularly in the paternal genome, indicating that this force, well documented in mammals, also operates in the basal chordate lineage.

The broader significance of this work is methodological as much as biological. Previous direct detections of recombination without gamete sequencing typically required pedigrees spanning three or more generations, and long-read sequencing approaches can cost more than ten times as much per unit of data. By exploiting bubble contigs as natural markers, the new pipeline achieves contig-level parental haplotyping from just two generations and affordable short-read data, offering a template for studying recombination in the many non-model organisms burdened with high heterozygosity. The findings illuminate both conserved features, such as short NCO tracts and GC-biased gene conversion, and divergent ones, including the absence of sex-biased crossover rates and the prevalence of inversion-driven coldspots, in a species that anchors our understanding of vertebrate origins. As the authors acknowledge, results from a single family cannot capture population-level diversity, and regions of lower heterozygosity remain under-sampled. Nevertheless, by transforming amphioxus’s genomic eccentricity into a high-resolution lens on meiosis, the study opens the door to recombination mapping across a wide swath of the living world that has until now remained largely invisible to geneticists.

Subject of Research: Direct genome-wide detection of meiotic crossover and non-crossover recombination events in the highly heterozygous amphioxus Branchiostoma floridae

Article Title: Direct detection of meiotic recombination events in the highly heterozygous amphioxus genome

Article References: Tao, L., Xue, J., Cao, J., Li, G., & Li, C. (2025). Direct detection of meiotic recombination events in the highly heterozygous amphioxus genome. Advanced Biotechnology, 3(4), Article 30. https://doi.org/10.1007/s44307-025-00083-7

Image Credits: AI Generated

DOI: 10.1007/s44307-025-00083-7

Keywords: amphioxus, meiotic recombination, crossover, non-crossover gene conversion, heterozygosity, Branchiostoma floridae, haplotype phasing, genome assembly, heterozygous inversions, GC-biased gene conversion, transposable elements, chordate evolution

The core of Demircan’s critique rests on a principle familiar to every epidemiologist: treatment effect and treatment selection are two very different things. When patients are not randomized, the group that receives one therapy is often systematically different from the group that receives another, and any difference in outcomes may reflect those baseline differences rather than the therapy itself. In the study under scrutiny, patients who underwent microsurgical resection had greater baseline motor impairment than those allocated to stereotactic radiotherapy. That detail matters enormously, because a patient who enters treatment with a weakened arm or leg has far more room to demonstrate measurable improvement than a patient whose motor function is already intact. Improvement in the surgical cohort and stability in the radiotherapy cohort may therefore describe the same underlying quality of care, even though the numbers appear to favor one arm over the other.

This asymmetry in scoring is more than a statistical quirk. Functional outcome scales typically capture change from baseline, so a patient who regains the ability to walk after tumor decompression registers a dramatic gain, while a patient who never lost the ability to walk and remains unchanged after focused radiation registers only stability. Yet clinically, preserving intact neurological function is precisely the goal of treating a metastasis in eloquent motor cortex without opening the brain. Demircan points out that categorizing preserved near-intact function after stereotactic radiotherapy as mere stability understates what is, for those patients, a meaningful and desirable result. The apparent superiority of surgery may, in part, be an artifact of the yardstick rather than a genuine therapeutic advantage.

The second major concern involves what statisticians call informative crossover, and here the numbers are striking. Of the 41 patients initially allocated to stereotactic radiotherapy, 17 ultimately required salvage surgery, either because their tumors progressed or because they developed a new neurological deficit despite irradiation. That is a crossover rate of roughly 41 percent, and all of those patients were excluded from the comparative radiotherapy cohort. What remains in the analyzed group is, by construction, the subset of patients for whom radiotherapy succeeded. This is a form of survivorship bias built directly into the study design: the radiotherapy arm is pre-selected for good outcomes, while the failures are silently transferred out of view. Any comparison between the trimmed radiotherapy cohort and the surgical cohort will therefore flatter radiotherapy less than an intention-to-treat analysis would, or, depending on how the comparison is framed, obscure the clinically important fact that a substantial minority of radiotherapy patients fared poorly and needed rescue operations.

Demircan emphasizes that this 41 percent crossover does double duty. It simultaneously selects the analyzed radiotherapy cohort for patients in whom the treatment worked, and it identifies a subgroup with genuinely poor outcomes after initial radiotherapy, patients who progressed or deteriorated neurologically and required surgery anyway. For clinicians counseling a patient, that subgroup is not a footnote; it is central to the decision. A patient with a metastasis in the motor cortex wants to know not only the average outcome of each strategy but also the risk that the first choice will fail and leave them worse off. When more than four in ten patients initially assigned to radiotherapy end up needing surgery, the effective comparison is no longer surgery versus radiotherapy but surgery versus radiotherapy followed, in many cases, by surgery after all.

A third layer of complexity concerns what the surgical arm actually received. Postoperative radiotherapy was administered to 95 percent of surgically treated patients with available data. This means the study did not compare surgery alone with radiotherapy alone; it compared a multimodality package, microsurgical resection followed by adjuvant irradiation, against definitive stereotactic radiotherapy. The distinction is far from academic. Landmark randomized trials, including the phase 3 studies by Mahajan and colleagues and Brown and colleagues published in Lancet Oncology in 2017, established that postoperative stereotactic radiosurgery reduces local recurrence after resection but carries its own considerations regarding toxicity and cognitive outcomes. Attributing the combined strategy’s results to surgery alone would misrepresent the intervention patients actually underwent and could mislead centers that lack the full multidisciplinary apparatus the combined approach presumes.

Compounding all of this, the extent of resection was not reported. In neurosurgical oncology, the degree to which a tumor is removed is one of the strongest determinants of local control, particularly when adjuvant radiation is planned. A gross-total resection followed by cavity radiosurgery behaves very differently biologically from a subtotal decompression, both in terms of residual tumor cells and in the dose constraints that nearby motor pathways impose on the radiation plan. Without knowing how complete the resections were, readers cannot disentangle how much of the local control in the surgical arm came from the operation itself and how much from the postoperative irradiation that nearly all of those patients received. Demircan argues that this missing variable further complicates any interpretation of the study’s local control data and its functional outcomes.

None of this means the study is without value. Demircan is explicit that the findings do support microsurgical resection for appropriately selected patients, particularly those with large, symptomatic lesions that require rapid decompression. When a tumor is exerting mass effect on motor pathways and a patient is losing function hour by hour, focused radiation cannot act quickly enough, and surgical relief is the only option that restores room for the brain to recover. The critique is narrower and more precise: the data do not establish that surgery produces better functional outcomes than stereotactic radiotherapy once treatment selection is properly accounted for. Those are two very different claims, and conflating them could push clinical practice toward aggressive intervention in patients who would do just as well, with less risk, under a radiation-first strategy.

The path forward, according to the correspondence, lies in how future studies are designed and reported. Outcomes should be tracked from the initial treatment allocation all the way through salvage therapy, so that the true cost of each starting strategy, including its failure rate, is visible rather than hidden by cohort trimming. Analyses should incorporate the variables that actually drive decisions and outcomes in this population: lesion volume, baseline neurological status, involvement of the corticospinal tract as mapped by diffusion tensor imaging and navigated transcranial magnetic stimulation, the extent of resection achieved, the burden of systemic disease, and the urgency of decompression. Advanced imaging and tractography techniques, already being used to spare motor structures in adjuvant radiotherapy planning, offer a way to individualize these decisions with far greater anatomical precision than was possible a decade ago.

For patients and clinicians, the takeaway is a familiar lesson in modern oncology delivered in an unfamiliar setting. Observational comparisons, however carefully assembled, are hostage to the forces that determine who receives which treatment. In motor cortex metastases, those forces, performance status, motor function, tumor size, and disease burden, are precisely the factors that also shape functional outcomes, making confounding especially potent. The study by Kraus and colleagues adds real evidence that surgery can serve selected patients well, and the correspondence by Demircan sharpens that evidence into something clinically usable: a reminder that preserved function after radiation is a success worth counting, that crossover is a result worth reporting, and that the question is not simply which treatment works, but which treatment works for which patient, under which circumstances, measured from the moment the first decision is made.

Subject of Research: Interpreting functional outcomes and treatment selection bias in managing brain metastases of the primary motor cortex

Article Title: Treatment selection or treatment effect? Interpreting functional outcomes in motor cortex metastases

Article References: Demircan, V. (2026). Treatment selection or treatment effect? Interpreting functional outcomes in motor cortex metastases. Journal of Neuro-Oncology, 179(2), Article 72. https://doi.org/10.1007/s11060-026-05787-x

Image Credits: AI Generated

DOI: 10.1007/s11060-026-05787-x

Keywords: brain metastases, motor cortex, microsurgical resection, stereotactic radiotherapy, treatment selection bias, functional outcomes, crossover, postoperative radiotherapy, extent of resection, corticospinal tract, neuro-oncology, salvage surgery